U.S. Physical Therapy, Inc. USPH R2K
Healthcare · Medical Care Facilities · United States
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
READ MORE ›$64.26
-12.15% 1Y
Market & Price
Market Cap
$977.96M
Current Price
$64.26
High / Low (52W)
$91.35 / $58.57
Beta
1.20
Valuation
Stock P/E
128.52
Industry PE
23.65
Forward P/E
18.83
PEG Ratio
2.32
Book Value
$31.50
Price to Book
2.04
P/S
1.24
EV/EBITDA
15.84
Dividend Yield
2.83%
Profitability & Returns
ROCE
8.19%
ROE
6.83%
ROA
4.13%
Profit Margin
4.41%
Op Margin
7.34%
EPS (Latest Qtr)
$-0.12
EPS (TTM)
$0.50
Balance Sheet & Liquidity
Debt/Equity
0.46
Quick Ratio
1.08
Current Ratio
1.19
Debt
$362.83M
Total Assets
$1.20B
Current Assets
$139.99M
Working Capital
$950.00K
Ownership
Promoter Holding
2.47%
Chg in Prom Hold
-
FII / Inst Holding
108.39%
Chg in FII Hold
-0.00%
Financial Snapshot
Enterprise Value
$1.63B
Total Revenue (TTM)
$787.68M
EBITDA
$102.58M
Free Cash Flow
$43.06M
Operating Cash Flow
$83.54M
Shares Outstanding
15.22M
Gross Margin
21.90%
Payout Ratio
362.00%
Growth (CAGR)
Revenue 5Y
12.19%
Profit 5Y
-18.93%
Revenue (YoY)
7.90%
Earnings (YoY)
-
PROS
- Compounding revenue at 12.2% over 5 years.
- Attractive dividend yield of 2.83%.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 128.5.
- Earnings shrank at -18.9% CAGR over 5 years.
- Trading 29.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | USPH U.S. Physical Therapy, Inc. R2K | 64.26 | 128.52 | $977.96M | 2.83% | 8.19% | 6.83% | 12.19% | -18.93% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 97.56M | 104.25M | 103.03M | 109.20M | 108.34M | 115.10M | 113.12M | 117.35M | 116.23M | 126.37M | 117.25M | 122.11M | 112.72M | 83.86M | 108.93M | 112.37M | 126.93M | 125.89M | 131.70M | 140.66M | 139.60M | 148.51M | 151.49M | 150.01M | 155.68M | 167.19M | 168.03M | 183.79M | 197.34M | 197.13M | 202.73M | 198.29M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 152.72M | 155.72M | 160.26M | 162.59M | 165.53M |
| Gross Profit | 16.84M | 21.14M | 18.87M | - | 20.50M | 23.06M | 19.66M | - | 20.75M | 24.53M | 21.19M | - | 23.21M | 27.15M | 26.08M | 25.22M | 26.72M | 31.43M | 27.37M | 26.96M | 15.69M | 19.28M | 30.36M | 25.90M | 34.30M | 29.80M | 26.59M | 30.82M | 26.78M | 30.86M | 32.21M | 27.93M | 28.40M | 33.86M | 29.13M | 31.07M | 41.62M | 36.87M | 40.13M | 32.75M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.25M | 17.48M | 17.41M | 18.12M | 18.27M |
| Operating Income | 9.19M | 13.55M | 11.95M | 12.61M | 11.49M | 15.03M | 12.05M | 10.95M | 12.20M | 15.68M | 12.89M | 13.96M | 13.05M | 17.03M | 15.43M | 14.80M | 15.43M | 19.90M | 16.82M | 15.29M | 4.01M | 10.26M | 19.93M | 15.02M | 22.23M | 16.93M | 15.03M | 20.08M | 14.89M | 17.00M | 20.06M | 15.88M | 14.93M | 15.57M | 12.85M | 14.82M | 24.15M | 19.46M | 22.01M | 14.48M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.47M | 31.13M | 31.11M | 21.94M | 19.35M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.28M | 2.42M | 2.41M | 2.35M | 2.79M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.33M | 22.65M | 22.88M | 14.96M | 10.56M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.86M | 4.93M | 5.23M | 5.78M | 2.41M |
| Net Income | 4.01M | 6.33M | 5.51M | - | 4.49M | 6.01M | 4.80M | - | 4.82M | 4.94M | 5.15M | - | 7.12M | 9.25M | 8.10M | - | 8.44M | 14.62M | 9.05M | - | 1.02M | 10.23M | 10.92M | 8.17M | 12.44M | 10.01M | 8.80M | 11.20M | 9.56M | 7.41M | 10.92M | 9.25M | 8.05M | 7.51M | 6.63M | 12.80M | 7.59M | 5.22M | -10.55M | -4.33M |
| Diluted EPS | 0.34 | 0.48 | 0.47 | 0.48 | 0.43 | 0.57 | 0.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20 | 0.99 | 0.61 | 0.21 | 0.82 | 0.66 | 0.67 | 0.87 | 0.72 | 0.58 | 0.64 | 0.51 | 0.46 | 0.47 | 0.39 | 0.80 | 0.58 | 0.48 | -0.44 | -0.12 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 356.55M | 414.05M | 453.91M | 481.97M | 422.97M | - | 553.14M | 604.80M | 671.35M | 780.99M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 441.12M | 483.29M | 547.42M | 631.30M |
| Gross Profit | - | 56.01M | 55.87M | 62.91M | 64.70M | 76.17M | 78.36M | 82.01M | 90.62M | 101.66M | 112.47M | 94.45M | - | 112.02M | 121.51M | 123.92M | 149.69M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 46.11M | 51.49M | 58.29M | 69.26M |
| Operating Income | 28.25M | 33.19M | 31.43M | 38.41M | 38.77M | 45.77M | 47.29M | 49.53M | 54.73M | 60.31M | 67.42M | 52.41M | - | 65.91M | 70.02M | 65.63M | 80.43M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 76.09M | 74.37M | 86.91M | 109.66M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.78M | 9.30M | 8.02M | 9.46M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.57M | 49.38M | 60.21M | 77.81M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.16M | 12.16M | 14.61M | 19.81M |
| Net Income | 11.77M | 15.64M | 20.97M | 17.93M | 12.72M | 19.13M | 20.61M | 20.55M | 22.26M | 34.87M | 40.04M | 35.19M | - | 28.27M | 14.67M | 26.46M | 15.06M |
| Diluted EPS | 1.00 | 1.32 | 1.75 | 1.51 | 1.05 | 1.62 | 1.77 | - | - | - | 2.45 | 2.48 | - | 2.25 | 1.28 | 1.84 | 1.42 |
Compounded Sales Growth
| 5 Years: | 12.19% |
| 1 Year: | 7.90% |
Compounded Profit Growth
| 5 Years: | -18.93% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -12.15% |
| 6 Months: | -12.19% |
| 3 Months: | -21.51% |
| 1 Month: | -9.48% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 140.86M | 163.25M | 171.71M | 224.13M | 244.55M | 281.25M | 292.15M | 299.97M | 303.76M | 335.74M | 338.00M | 334.54M | 351.23M | 418.98M | 443.17M | 630.50M | 594.36M | - | 858.15M | 997.24M | 1.17B | 1.20B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 111.27M | 233.38M | 137.58M | 139.99M |
| Cash & Equivalents | - | - | 9.18M | 9.98M | 11.67M | 12.90M | 14.27M | 14.56M | 12.97M | 20.56M | 15.78M | 19.21M | 20.45M | 15.02M | 20.05M | 21.93M | 23.37M | 23.55M | 32.92M | - | 31.59M | 152.82M | 41.36M | 35.57M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 68.61M | 51.87M | 59.04M | 64.25M |
| Total Liabilities | - | - | 24.48M | 41.67M | 37.05M | 69.01M | 69.96M | 123.44M | 128.92M | 131.60M | 131.45M | 159.50M | 156.32M | 149.17M | 162.54M | 110.34M | 92.35M | 181.39M | 184.39M | - | 373.59M | 345.00M | 408.42M | 433.81M |
| Current Liabilities | - | - | 14.23M | 16.32M | 16.31M | 23.17M | 25.50M | 21.40M | 21.70M | 21.36M | 19.01M | 24.18M | 28.98M | 26.38M | 24.62M | 39.55M | 41.95M | 60.56M | 93.49M | - | 85.49M | 102.19M | 116.28M | 139.04M |
| Long Term Debt | - | - | - | 23.78M | 17.57M | 40.65M | 34.73M | - | - | - | 48.34M | - | - | - | 50.60M | 56.73M | 38.40M | 50.36M | 16.60M | - | 175.83M | 138.99M | 142.53M | 152.59M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 295.34M | 258.59M | 295.23M | 315.17M |
| Total Equity | 87.82M | 92.22M | 103.96M | 107.05M | 117.32M | 128.29M | 146.28M | 156.11M | 161.33M | 166.84M | 171.06M | 174.73M | 180.29M | 184.24M | 187.55M | 204.87M | 215.94M | 240.26M | 276.16M | - | 315.79M | 476.19M | 488.93M | 476.43M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.22M | 17.20M | 17.31M | 17.42M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 30.94M | 30.52M | 32.66M | 39.25M | 44.80M | 45.19M | 37.52M | 51.05M | 56.53M | 73.00M | 62.45M | 100.00M | - | 58.54M | 81.98M | 74.94M | 75.06M |
| Investing Cash Flow | -7.33M | -21.63M | -31.61M | -14.10M | -52.45M | -22.88M | -26.12M | -32.49M | -43.58M | -23.91M | -37.99M | -51.20M | - | -81.27M | -45.02M | -149.45M | -36.71M |
| Financing Cash Flow | -27.30M | -6.14M | -245.00K | -23.46M | 8.88M | -20.94M | -9.89M | -14.29M | -11.06M | -47.66M | -24.27M | -39.42M | - | 25.76M | 84.27M | -36.95M | -44.14M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -8.25M | -9.29M | -9.19M | -14.07M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.29M | 72.68M | 65.75M | 60.99M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.03M | 121.23M | -111.46M | -5.79M |
| Share Buybacks | 5.59M | 1.40M | 4.66M | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 5.57M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | 23.0% | 21.9% | 22.4% | 23.3% | 22.3% | - | 20.3% | 20.1% | 18.5% | 19.2% |
| Operating Margin % | - | - | - | - | - | - | - | 13.9% | 13.2% | 13.3% | 14.0% | 12.4% | - | 11.9% | 11.6% | 9.8% | 10.3% |
| Net Margin % | - | - | - | - | - | - | - | 5.8% | 5.4% | 7.7% | 8.3% | 8.3% | - | 5.1% | 2.4% | 3.9% | 1.9% |
| ROE % | 12.8% | 15.0% | 19.6% | 15.3% | 9.9% | 13.1% | 12.1% | 11.0% | 10.9% | 16.1% | 16.7% | 12.7% | - | 9.0% | 3.1% | 5.4% | 3.2% |
| ROCE % | - | 26.2% | 21.4% | 24.7% | 19.3% | 20.9% | 16.6% | 15.2% | 14.4% | 15.0% | 11.8% | 10.5% | - | 8.5% | 7.8% | 6.2% | 7.6% |
Shareholding Pattern
Insiders
2.47%
Institutions
108.39%
Public Float
111.13%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.51% | 2.21M | $141.92M |
| 2 | Kayne Anderson Rudnick Investment Management LLC | 7.00% | 1.07M | $68.49M |
| 3 | Morgan Stanley | 6.59% | 1.00M | $64.42M |
| 4 | Bahl & Gaynor, Inc. | 5.55% | 845.39K | $54.32M |
| 5 | Copeland Capital Management, LLC | 5.50% | 836.83K | $53.77M |
| 6 | Vanguard Capital Management LLC | 4.36% | 664.06K | $42.67M |
| 7 | State Street Corporation | 4.26% | 648.39K | $41.67M |
| 8 | Bank of America Corporation | 3.64% | 554.62K | $35.64M |
| 9 | Dimensional Fund Advisors LP | 3.33% | 507.39K | $32.61M |
| 10 | SouthernSun Asset Management, LLC | 2.89% | 439.90K | $28.27M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for USPH
No recent headlines available.